Default: British Journal of Pharmacology

ISSN: 0007-1188

Journal Home

Journal Guideline

British Journal of Pharmacology Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

British Journal of Pharmacology is a journal indexed in SJR in Pharmacology with an H index of 202. It has a price of 3429 €. It has an SJR impact factor of 2,493 and it has a best quartile of Q1. It is published in English.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

WOS Scopus
Categories: Pharmacology (Q1)

3429 €

Gold OA


Green OA

0 €

Non OA


British Journal of Pharmacology


SJR Impact factor


H Index


Total Docs (Last Year)


Total Docs (3 years)


Total Refs


Total Cites (3 years)


Citable Docs (3 years)


Cites/Doc (2 years)



Best articles

[125I]-(Pyr1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man

View more

3,5-Dibenzoyl-4-(3-phenoxyphenyl)-1,4-dihydro-2,6-dimethylpyridine (DP7) as a new multidrug resistance reverting agent devoid of effects on vascular smooth muscle contractility

View more

5-Hydroxytryptamine is biotransformed by CYP2C9, 2C19 and 2B6 to hydroxylamine, which is converted into nitric oxide

View more

A structural model of agonist binding to thea3beta4 neuronal nicotinic receptor

View more

a1-Adrenoceptor subtypes involved in vasoconstrictor responses to exogenous and neurally released noradrenaline in rat femoral resistance arteries

View more

Agonist-activated ion channels

View more

Agonist-dependence of recovery from desensitization of P2X3receptors provides a novel and sensitive approach for their rapid up or downregulation

View more

Alpha-1 adrenoceptors: evaluation of receptor subtype-binding kinetics in intact arterial tissues and comparison with membrane binding

View more

Angiotensin II, a stress-related neuropeptide in the CNS, facilitates micturition reflex in rats

View more

Antagonism of the antithrombotic and anti-atherosclerotic actions of aspirin by rofecoxib in the cholesterol-fed rabbit

View more

Antiplatelet and antithrombotic effect of F 16618, a new thrombin proteinase-activated receptor-1 (PAR1) antagonist

View more

ATP-induced vasodilation in human skeletal muscle

View more

Binding of the prototypical adenosine A2Areceptor agonist CGS 21680 to the cerebral cortex of adenosine A1and A2Areceptor knockout mice

View more

Cannabinoid CB1receptor-mediated modulation of evoked dopamine release and of adenylyl cyclase activity in the human neocortex

View more

Changes in the vascularbeta-adrenoceptor-activated signalling pathway in 2Kidney-1Clip hypertensive rats

View more

Characterisation of the vasorelaxant properties of the novel endocannabinoidN-arachidonoyl-dopamine (NADA)

View more

Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study

View more

Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats

View more

Comparison of U46619-, endothelin-1- or phenylephrine-induced changes in cellular Ca2+profiles and Ca2+sensitisation of constriction of pressurised rat resistance arteries

View more

Correlation between spontaneous electrical, calcium and mechanical activity in detrusor smooth muscle of the guinea-pig bladder

View more

Corrigendum to Halogenation of a capsaicin analogue leads to novel vanilloid TRPVI receptor antagonists

View more

Decreased expression of glial cell line-derived neurotrophic factor signaling in rat models of neuropathic pain

View more

Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons

View more

Differential modulation of ATP-induced calcium signalling by A1 and A2 adenosine receptors in cultured cortical astrocytes

View more


No comments ... Be the first to comment!